From October 27, 2023 to December 31, 2023, the company has repurchased 660,000 shares, representing 0.12% for CNY 19.39 million. With this, the company has completed the repurchase of 660,000 shares, representing 0.12% for CNY 19.39 million under the buyback announced on October 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.38 CNY | -6.00% |
|
-6.35% | -50.78% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.78% | 931M | |
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.